Quick Answer
ANAPTYSBIO, INC reported Operating Income of $47.90 million for fiscal year 2025.
ANAPTYSBIO, INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $47.90M | +141.7% |
| 2024 | -$114.95M | +30.1% |
| 2023 | -$164.41M | -42.8% |
| 2022 | -$115.15M | -102.7% |
| 2021 | -$56.81M | -137.9% |
| 2020 | -$23.88M | +77.8% |
| 2019 | -$107.43M | -61.0% |
| 2018 | -$66.72M | -131.8% |
| 2017 | -$28.78M | -851.4% |
| 2016 | -$3.02M | +8.9% |
| 2015 | -$3.32M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $34.70M | +252.5% | +232.6% |
| June 30, 2025 | -$26.17M | +35.1% | +5.0% |
| March 31, 2025 | -$27.54M | +34.7% | -21.0% |
| September 30, 2024 | -$22.76M | +39.7% | +43.6% |
| June 30, 2024 | -$40.32M | -0.4% | +4.5% |
| March 31, 2024 | -$42.20M | +5.0% | -11.8% |
| September 30, 2023 | -$37.73M | -27.3% | +6.0% |
| June 30, 2023 | -$40.14M | -44.4% | +9.6% |
- ANAPTYSBIO, INC showed an increase of +141.7% in Operating Income compared to the prior fiscal year.
- Over the 2015–2025 period, ANAPTYSBIO, INC’s operating income has grown by 1541.8% (from -$3.32 million to $47.90 million).
- The most recent figure is from ANAPTYSBIO, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: